The ventricle assist device market is projected to grow from USD 4.0 billion in 2025 to USD 20.5 billion by 2035, at a CAGR of 17.6%. Implantable Ventricle Assist Devices will dominate with a 54.6% market share, while lvad (left ventricle assist devices) will lead the product type segment with a 38.2% share.